| United Therapeutics Corporation | 46,222 | US$25M | 3.2% |
| Cogent Biosciences, Inc. | 642K | US$20.6M | 2.6% |
| Abivax SA | 178K | US$17.7M | 2.3% |
| BioMarin Pharmaceutical Inc. | 255K | US$15.3M | 2.0% |
| Revolution Medicines, Inc. | 70,004 | US$14.4M | 1.8% |
| Viking Therapeutics, Inc. | 433K | US$14.1M | 1.8% |
| BridgeBio Pharma, Inc. | 104K | US$6.84M | 0.88% |
| Immunocore Holdings plc | 222K | US$6.72M | 0.86% |
| 4D Molecular Therapeutics, Inc. | 421K | US$6.03M | 0.77% |
| Viridian Therapeutics, Inc. | 257K | US$5.29M | 0.68% |
| Johnson & Johnson | 17,000 | US$4.5M | 0.58% |
| Indivior Pharmaceuticals, Inc. | 118K | US$4.21M | 0.54% |
| Vaxcyte, Inc. | 72,850 | US$4.15M | 0.53% |
| Replimune Group, Inc. | 305K | US$4.04M | 0.52% |
| Arcus Biosciences, Inc. | 154K | US$3.97M | 0.51% |
| Kodiak Sciences Inc | 38,991 | US$3.7M | 0.47% |
| Liquidia Corporation | 120K | US$3.63M | 0.47% |
| MBX Biosciences, Inc. | 60,000 | US$3.52M | 0.45% |
| Rhythm Pharmaceuticals, Inc. | 30,000 | US$2.86M | 0.37% |
| Avalo Therapeutics, Inc. | 182K | US$2.79M | 0.36% |
| Corvus Pharmaceuticals, Inc. | 205K | US$2.36M | 0.30% |
| MannKind Corporation | 604K | US$2.36M | 0.30% |
| Insmed Incorporated | 18,497 | US$2.11M | 0.27% |
| BioCryst Pharmaceuticals, Inc. | 250K | US$2.08M | 0.27% |
| Inventiva SA | 553K | US$2.06M | 0.26% |
| Taysha Gene Therapies, Inc. | 423K | US$2.06M | 0.26% |
| Spruce Biosciences, Inc. | 40,435 | US$1.96M | 0.25% |
| Edgewise Therapeutics, Inc. | 44,346 | US$1.8M | 0.23% |
| Pelthos Therapeutics Inc. | 80,760 | US$1.7M | 0.22% |
| Amylyx Pharmaceuticals, Inc. | 53,152 | US$1.55M | 0.20% |
| Bicycle Therapeutics PLC | 399K | US$1.47M | 0.19% |
| Relmada Therapeutics, Inc. | 361K | US$1.36M | 0.17% |
| Phathom Pharmaceuticals, Inc. | 180K | US$1.31M | 0.17% |
| Jade Biosciences, Inc. | 91,259 | US$1.28M | 0.16% |
| Mineralys Therapeutics, Inc. | 50,000 | US$1.26M | 0.16% |
| Vera Therapeutics, Inc. | 38,008 | US$1.23M | 0.16% |
| Oruka Therapeutics, Inc. | 13,169 | US$1.1M | 0.14% |
| MacroGenics, Inc. | 262K | US$1.01M | 0.13% |
| Jasper Therapeutics, Inc. | 35,271 | US$874K | 0.11% |
| Contineum Therapeutics, Inc. | 64,549 | US$866K | 0.11% |
| Adial Pharmaceuticals, Inc | 182K | US$729K | 0.09% |
| Summit Therapeutics Inc. | 41,887 | US$708K | 0.09% |
| NovaBridge Biosciences | 500K | US$683K | 0.09% |
| Quoin Pharmaceuticals. Ltd | 146K | US$668K | 0.09% |
| Kardigan, Inc. | 43,972 | US$649K | 0.08% |
| Entrada Therapeutics, Inc. | 100K | US$635K | 0.08% |
| Tango Therapeutics, Inc. | 25,000 | US$624K | 0.08% |
| SELLAS Life Sciences Group, Inc. | 50,000 | US$616K | 0.08% |
| Larimar Therapeutics, Inc. | 186K | US$593K | 0.08% |
| Silence Therapeutics PLC | 135K | US$540K | 0.07% |
| Nurix Therapeutics, Inc. | 21,539 | US$511K | 0.07% |
| Fulcrum Therapeutics, Inc. | 133K | US$494K | 0.06% |
| Enliven Therapeutics, Inc. | 10,000 | US$458K | 0.06% |
| Talphera, Inc. | 378K | US$439K | 0.06% |
| Xenon Pharmaceuticals Inc. | 10,000 | US$372K | 0.05% |
| Abeona Therapeutics Inc. | 51,117 | US$268K | 0.03% |
| Ardelyx, Inc. | 77,133 | US$264K | 0.03% |
| Ocugen, Inc. | 200K | US$206K | 0.03% |
| Attovia Therapeutics, Inc. | 9,700 | US$166K | 0.02% |
| Heron Therapeutics, Inc. | 459K | US$144K | 0.02% |
| Aytu BioPharma, Inc. | 67,186 | US$144K | 0.02% |
| JATT II Acquisition Corp | 12,174 | US$137K | 0.02% |
| Cellectar Biosciences, Inc. | 71,382 | US$131K | 0.02% |
| Palisade Bio, Inc. | 69,533 | US$93,870 | 0.01% |
| Enanta Pharmaceuticals, Inc. | 5,503 | US$72,530 | <0.01% |
| Eli Lilly and Company | 60 | US$69,425 | <0.01% |
| Tvardi Therapeutics, Inc. | 48,491 | US$60,614 | <0.01% |
| Aprea Therapeutics, Inc. | 28,872 | US$21,654 | <0.01% |
| Outlook Therapeutics, Inc. | 35,000 | US$20,073 | <0.01% |
| Elicio Therapeutics, Inc. | 9,440 | US$17,181 | <0.01% |
| MaxCyte, Inc. | 8,190 | US$9,173 | <0.01% |
| Intellia Therapeutics, Inc. | 124 | US$1,495 | <0.01% |
| NextCure, Inc. | 0 | US$0 | 0.00% |
| Novo Nordisk A/S Class B | 0 | US$0 | 0.00% |
| PepGen Inc. | 0 | US$0 | 0.00% |
| Precigen, Inc. | 0 | US$0 | 0.00% |
| Relay Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Rigel Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Spyre Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Unicycive Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Upstream Bio, Inc. | 0 | US$0 | 0.00% |
| Voyager Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Xeris Biopharma Holdings, Inc. | 0 | US$0 | 0.00% |
| Zymeworks Inc. | 0 | US$0 | 0.00% |
| Annexon, Inc. | 0 | US$0 | 0.00% |
| ARS Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| BioAge Labs, Inc. | 0 | US$0 | 0.00% |
| Cartesian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Connect Biopharma Holdings Limited | 0 | US$0 | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. | 0 | US$0 | 0.00% |
| Cue Biopharma, Inc. | 0 | US$0 | 0.00% |
| Cybin, Inc. | 0 | US$0 | 0.00% |
| Definium Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Equillium, Inc. | 0 | US$0 | 0.00% |
| Foghorn Therapeutics Inc. | 0 | US$0 | 0.00% |
| Harmony Biosciences Holdings, Inc. | 0 | US$0 | 0.00% |
| Kailera Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Lakeland Industries, Inc. | 0 | US$0 | 0.00% |
| MeiraGTx Holdings plc | 0 | US$0 | 0.00% |
| Monopar Therapeutics Inc. | 0 | US$0 | 0.00% |